HDAC4 and nasopharyngeal carcinoma: HDAC4 has been considered as a promising therapeutic target for multiple cancers, including gastric cancer, nasopharyngeal carcinoma and colon cancer, due to its effects on promoting the growth and metastasis of tumors (Cheng et al. 2021; Zang et al. 2022).